01888nas a2200217 4500000000100000008004100001260001600042653002400058653001700082653001700099100001600116700001600132700001200148700001500160700001400175245007300189856015300262300000900415520123200424022001401656 2023 d bElsevier BV10aInfectious Diseases10aParasitology10aEpidemiology1 aZargaran FN1 aRostamian M1 aKooti S1 aMadanchi H1 aGhadiri K00aCo-infection of COVID-19 and parasitic diseases: A systematic review uhttps://www.sciencedirect.com/science/article/pii/S2405673123000168/pdfft?md5=667af5b37486c01b1171b25880d4e906&pid=1-s2.0-S2405673123000168-main.pdf a1-353 a

Co-infection of COVID-19 with other diseases increases the challenges related to its treatment management. COVID-19 co-infection with parasites is studied with low frequency. Here, we systematically reviewed the cases of parasitic disease co-infection with COVID-19. All articles on COVID-19 co-infected with parasites (protozoa, helminths, and ectoparasites), were screened through defined inclusion/exclusion criteria.

Of 2190 records, 35 studies remained for data extraction. The majority of studies were about COVID-19 co-infected with malaria, followed by strongyloidiasis, amoebiasis, chagas, filariasis, giardiasis, leishmaniasis, lophomoniasis, myiasis, and toxoplasmosis. No or low manifestation differences were reported between the co-infected cases and naïve COVID-19 or naïve parasitic disease.

Although there was a relatively low number of reports on parasitic diseases-COVID-19 co-infection, COVID-19 and some parasitic diseases have overlapping symptoms and also COVID-19 conditions and treatment regimens may cause some parasites re-emergence, relapse, or re-activation. Therefore, more attention should be paid to the on-time diagnosis of COVID-19 and the co-infected parasites.

 a2405-6731